Trials / Conditions / Microsatellite Stable (MSS) Colorectal Cancer (CRC)
Microsatellite Stable (MSS) Colorectal Cancer (CRC)
3 registered clinical trials studyying Microsatellite Stable (MSS) Colorectal Cancer (CRC) — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Trial of Atezolizumab, Bevacizumab, and Tiragolumab in Patients With Microsatellite Stable, Metastatic Colorec NCT06784947 | University of Colorado, Denver | Phase 2 |
| Not Yet Recruiting | SBRT Combined With CAPEOX, Bevacizumab, and PD-1 Inhibitor for the Treatment of RAS-Mutant, MSS-Type, Unresect NCT06835179 | The First Affiliated Hospital with Nanjing Medical University | Phase 2 |
| Active Not Recruiting | AN0025 and Pembrolizumab Combination in Advanced Solid Tumors NCT04432857 | Adlai Nortye Biopharma Co., Ltd. | Phase 1 |